Randomised, Double-Blind, Placebo-Controlled Trial of Ivabradine in Patients with Acute Coronary Syndrome: Effects of the If Current Inhibitor Ivabradine on Reduction of Inflammation Markers in Patients with Acute Coronary Syndrome—RIVIERA Trial Study Design and Rationale

被引：0
|
作者：
Alberto Dominguez-Rodriguez
Sima Samimi Fard
Pedro Abreu-Gonzalez
Francisco Bosa-Ojeda
Luciano Consuegra-Sanchez
Alejandro Jiménez-Sosa
Alejandro Sánchez Grande
Juan Carlos Kaski
机构：
[1] University Hospital of Canarias,Department of Cardiology
[2] University of La Laguna,Department of Physiology
[3] Hospital Universitario del Rosell,Department of Cardiology
[4] University Hospital of Canarias,Cardiovascular Biology Research Centre, Division of Cardiac and Vascular Sciences
[5] Research Unit,Department of Cardiology, Coronary Care Unit
[6] St. George’s,undefined
[7] University of London,undefined
[8] University Hospital of Canarias,undefined
来源：
Cardiovascular Drugs and Therapy | 2009年 / 23卷
关键词：
Inflammation; Ivabradine; Acute coronary syndromes; C-reactive protein;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：243 / 247
页数：4
相关论文
共 50 条
  • [1] Randomised, Double-Blind, Placebo-Controlled Trial of Ivabradine in Patients with Acute Coronary Syndrome: Effects of the If Current Inhibitor Ivabradine on Reduction of Inflammation Markers in Patients with Acute Coronary Syndrome-RIVIERA Trial Study Design and Rationale
    Dominguez-Rodriguez, Alberto
    Samimi Fard, Sima
    Abreu-Gonzalez, Pedro
    Bosa-Ojeda, Francisco
    Consuegra-Sanchez, Luciano
    Jimenez-Sosa, Alejandro
    Sanchez Grande, Alejandro
    Carlos Kaski, Juan
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (03) : 243 - 247
  • [2] Citrus aurantium Aroma for Anxiety in Patients with Acute Coronary Syndrome: A Double-Blind Placebo-Controlled Trial
    Moslemi, Farhad
    Alijaniha, Fatemeh
    Naseri, Mohsen
    Kazemnejad, Anoshirvan
    Charkhkar, Mahsa
    Heidari, Mohammad Reza
    [J]. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2019, 25 (08) : 833 - 839
  • [3] The effects of topical heat therapy on chest pain in patients with acute coronary syndrome: a randomised double-blind placebo-controlled clinical trial
    Mohammadpour, Ali
    Mohammadian, Batol
    Moghadam, Mehdi Basiri
    Nematollahi, Mahmoud Reza
    [J]. JOURNAL OF CLINICAL NURSING, 2014, 23 (23-24) : 3460 - 3467
  • [4] Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial
    Tardif, Jean-Claude
    McMurray, John J. V.
    Klug, Eric
    Small, Robert
    Schumi, Jennifer
    Choi, Jasmine
    Cooper, Jim
    Scott, Robert
    Lewis, Eldrin F.
    L'Allier, Philippe L.
    Pfeffer, Marc A.
    [J]. LANCET, 2008, 371 (9626): : 1761 - 1768
  • [5] Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure
    Fox, Kim
    Ford, Ian
    Steg, Philippe Gabriel
    Tardif, Jean-Claude
    Tendera, Michal
    Ferrari, Roberto
    [J]. AMERICAN HEART JOURNAL, 2013, 166 (04) : 654 - +
  • [6] Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial (SHIFT)
    Swedberg, Karl
    Komajda, Michel
    Boehm, Michael
    Borer, Jeffrey S.
    Ford, Ian
    Tavazzi, Luigi
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (01) : 75 - 81
  • [7] Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction:: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) Study
    Fox, Kim
    Ferrari, Roberto
    Tendera, Michal
    Steg, Philippe Gabriel
    Ford, Ian
    [J]. AMERICAN HEART JOURNAL, 2006, 152 (05) : 860 - 866
  • [8] Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
    Fox, Kim
    Ford, Ian
    Steg, P. Gabriel
    Tendera, Michal
    Ferrari, Roberto
    [J]. LANCET, 2008, 372 (9641): : 807 - 816
  • [9] Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial) [ISRCTN81331696]
    Ostadal, P
    Alan, D
    Hajek, P
    Vejvoda, J
    Mates, M
    Blasko, P
    Veselka, J
    Kvapil, M
    Kettner, J
    Wiendl, M
    Aschermann, O
    Slaby, J
    Nemecek, E
    Holm, F
    Rac, M
    Macek, M
    Cepova, J
    [J]. CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE, 2005, 6 (1):
  • [10] Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]
    Petr Ostadal
    David Alan
    Petr Hajek
    Jiri Vejvoda
    Martin Mates
    Peter Blasko
    Josef Veselka
    Milan Kvapil
    Jiri Kettner
    Martin Wiendl
    Ondrej Aschermann
    Josef Slaby
    Eduard Nemecek
    Frantisek Holm
    Marek Rac
    Milan Macek
    Jana Cepova
    [J]. Current Controlled Trials in Cardiovascular Medicine, 2005, 6
12345